BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23578443)

  • 21. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort.
    Liu WR; Li CY; Xu WH; Liu XJ; Tang HD; Huang HN
    Aging (Albany NY); 2020 Jul; 12(13):13684-13700. PubMed ID: 32658870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
    Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
    Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fos-related antigen 1 modulates malignant features of glioma cells.
    Debinski W; Gibo DM
    Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of peroxisome proliferator-activated receptor gamma in glioma].
    Wang MH; Zhong XY; Lin CL; Xie YK; Jia JP; Li SM; Mi C
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):444-6. PubMed ID: 18359709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic power of a lipid metabolism gene panel for diffuse gliomas.
    Wu F; Zhao Z; Chai RC; Liu YQ; Li GZ; Jiang HY; Jiang T
    J Cell Mol Med; 2019 Nov; 23(11):7741-7748. PubMed ID: 31475440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
    Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
    Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.
    Liu L; Wu J; Ying Z; Chen B; Han A; Liang Y; Song L; Yuan J; Li J; Li M
    Cancer Res; 2010 May; 70(9):3750-9. PubMed ID: 20388776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
    Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
    Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
    Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [cDNA array in the establishment of a gene expression profile associated with differentiation inducing the glioma cells].
    Sun L; Huang Q; Wang A; Lan Q; Du Z; Hu G
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):222-5. PubMed ID: 12515611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of CD68 and kallikrein 6 in human glioma.
    Strojnik T; Kavalar R; Zajc I; Diamandis EP; Oikonomopoulou K; Lah TT
    Anticancer Res; 2009 Aug; 29(8):3269-79. PubMed ID: 19661345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
    Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
    Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression study of DNA translesion synthesis genes in human primary glioma].
    Xi CH; Hu J; Wang HB; Zhang SY; Ru DL
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1309-12. PubMed ID: 19615182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
    Persson O; Krogh M; Saal LH; Englund E; Liu J; Parsons R; Mandahl N; Borg A; Widegren B; Salford LG
    J Neurooncol; 2007 Oct; 85(1):11-24. PubMed ID: 17634744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma.
    Malmer B; Henriksson R; Grönberg H
    Neuroepidemiology; 2002; 21(6):279-86. PubMed ID: 12411730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome and coexpression network analysis of the human glioma cell line Hs683 exposed to candoxin.
    Jiang YX; Ma Y; Cheng Y
    J Int Med Res; 2012; 40(3):887-98. PubMed ID: 22906261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis of the genomic and transcriptional profile of high-grade gliomas in different age groups.
    Yang P; Liu Q; Tao R; Shan X; Huang R; Wang K; Wang J
    Clin Immunol; 2021 May; 226():108719. PubMed ID: 33819578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of combination gene sets for glioma classification.
    Kim S; Dougherty ER; Shmulevich I; Hess KR; Hamilton SR; Trent JM; Fuller GN; Zhang W
    Mol Cancer Ther; 2002 Nov; 1(13):1229-36. PubMed ID: 12479704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening key genes and pathways in glioma based on gene set enrichment analysis and meta-analysis.
    Tang Y; He W; Wei Y; Qu Z; Zeng J; Qin C
    J Mol Neurosci; 2013 Jun; 50(2):324-32. PubMed ID: 23494636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings.
    Hammad R; Nobre L; Ryall S; Arnoldo A; Siddaway R; Bennett J; Tabori U; Hawkins C
    JCO Glob Oncol; 2024 May; 10():e2300269. PubMed ID: 38754050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.